Cargando…
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
INTRODUCTION: Complexes between cartilage oligomeric matrix protein (COMP) and the complement activation product C3b have been found in the circulation of patients with rheumatoid arthritis and systemic lupus erythematosus. In systemic sclerosis (SSc) COMP expression in the skin is upregulated both...
Autores principales: | Otteby, Kaisa E, Holmquist, Emelie, Saxne, Tore, Heinegård, Dick, Hesselstrand, Roger, Blom, Anna M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978716/ https://www.ncbi.nlm.nih.gov/pubmed/24330664 http://dx.doi.org/10.1186/ar4410 |
Ejemplares similares
-
Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
por: Crnkic, Meliha, et al.
Publicado: (2003) -
Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
por: Andersson, Maria LE, et al.
Publicado: (2006) -
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
por: Okrój, Marcin, et al.
Publicado: (2016) -
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012) -
Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023)